IL143063A0 - Cross-linked hyaluronic acids and medical uses thereof - Google Patents

Cross-linked hyaluronic acids and medical uses thereof

Info

Publication number
IL143063A0
IL143063A0 IL14306399A IL14306399A IL143063A0 IL 143063 A0 IL143063 A0 IL 143063A0 IL 14306399 A IL14306399 A IL 14306399A IL 14306399 A IL14306399 A IL 14306399A IL 143063 A0 IL143063 A0 IL 143063A0
Authority
IL
Israel
Prior art keywords
cross
linked hyaluronic
hyaluronic acids
medical uses
linked
Prior art date
Application number
IL14306399A
Other languages
English (en)
Original Assignee
Aquisitio S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11381033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL143063(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aquisitio S P A filed Critical Aquisitio S P A
Publication of IL143063A0 publication Critical patent/IL143063A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IL14306399A 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof IL143063A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.
PCT/EP1999/008481 WO2000027887A2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof

Publications (1)

Publication Number Publication Date
IL143063A0 true IL143063A0 (en) 2002-04-21

Family

ID=11381033

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14306399A IL143063A0 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof

Country Status (24)

Country Link
US (1) US6831172B1 (xx)
EP (1) EP1144459B2 (xx)
JP (1) JP2002529550A (xx)
KR (1) KR100674177B1 (xx)
CN (1) CN1131241C (xx)
AT (1) ATE225371T1 (xx)
AU (1) AU757102B2 (xx)
BR (1) BR9915235A (xx)
CA (1) CA2350667A1 (xx)
CZ (1) CZ296842B6 (xx)
DE (1) DE69903351T3 (xx)
DK (1) DK1144459T4 (xx)
ES (1) ES2184521T5 (xx)
HK (1) HK1041011B (xx)
HU (1) HU229668B1 (xx)
IL (1) IL143063A0 (xx)
IT (1) IT1303735B1 (xx)
NO (1) NO20012315L (xx)
NZ (1) NZ511306A (xx)
PT (1) PT1144459E (xx)
RU (1) RU2230752C2 (xx)
TR (1) TR200101324T2 (xx)
WO (1) WO2000027887A2 (xx)
ZA (1) ZA200103799B (xx)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD980037A1 (it) * 1998-02-25 1999-08-25 Fidia Advanced Biopolymers Srl Acido ialuronico solfatato e i suoi derivati legati covalentemente a polimeri sintetici pe la preparazione di biomateriali e per il rivesti
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US7068729B2 (en) 2001-12-21 2006-06-27 Digital Fountain, Inc. Multi-stage code generator and decoder for communication systems
US6307487B1 (en) 1998-09-23 2001-10-23 Digital Fountain, Inc. Information additive code generator and decoder for communication systems
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
ATE376824T1 (de) 1999-01-13 2007-11-15 Alchemia Oncology Pty Ltd Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln
KR100338179B1 (ko) * 2000-05-08 2002-05-24 김범철 안질환 치료용 약물 전달을 위한 그래프트 중합체 및 그제조방법
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
KR100375299B1 (ko) * 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
JP4430867B2 (ja) * 2001-01-16 2010-03-10 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 基材／血液境界面で、ｉｎｓｉｔｕで、生体触媒により生じる、生体疑似的な（ｂｉｏｍｉｍｅｔｉｃ）一酸化窒素の生成
US7335383B2 (en) 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
WO2003018062A1 (en) * 2001-08-27 2003-03-06 Meditech Research Limited Improved therapeutic protocols
US9240810B2 (en) 2002-06-11 2016-01-19 Digital Fountain, Inc. Systems and processes for decoding chain reaction codes through inactivation
KR20040009891A (ko) * 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
JP4546246B2 (ja) 2002-10-05 2010-09-15 デジタル ファウンテン， インコーポレイテッド 連鎖的暗号化反応の系統的記号化および復号化
WO2004037120A2 (en) * 2002-10-25 2004-05-06 Essentia Biosystems, Inc. Implantable medical devices using zinc
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
JP4638817B2 (ja) 2003-02-21 2011-02-23 テルモ株式会社 架橋性多糖誘導体、その製造方法、架橋性多糖組成物および医療用処置材
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
EP1610838A1 (en) * 2003-04-04 2006-01-04 Bayco Tech Limited Vascular stent
CN1954501B (zh) 2003-10-06 2010-06-16 数字方敦股份有限公司 通过通信信道接收从源发射的数据的方法
JP4511470B2 (ja) 2003-10-29 2010-07-28 帝人株式会社 ヒアルロン酸化合物、そのハイドロゲルおよび関節軟骨損傷治療用材料
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
EP1743431A4 (en) 2004-05-07 2007-05-02 Digital Fountain Inc SYSTEM FOR DOWNLOADING AND RECORDING AND CONTINUOUS READING OF FILES
ITMI20041373A1 (it) 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
JP5060131B2 (ja) * 2004-09-07 2012-10-31 中外製薬株式会社 水溶性ヒアルロン酸修飾物の製造方法
WO2006051950A1 (ja) * 2004-11-15 2006-05-18 Shiseido Co., Ltd. 架橋ヒアルロン酸ゲルの製造方法
ES2636998T3 (es) * 2004-11-24 2017-10-10 Albumedix A/S Método de reticulación de ácido hialurónico con divinil sulfona
EP1833882A1 (en) * 2004-12-30 2007-09-19 Novozymes Biopolymer A/S Hyaluronic acid linked with a polymer of an alpha hydroxy acid
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
TW200643033A (en) * 2005-03-08 2006-12-16 Chugai Pharmaceutical Co Ltd Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
US7676735B2 (en) 2005-06-10 2010-03-09 Digital Fountain Inc. Forward error-correcting (FEC) coding and streaming
CA2616607C (en) 2005-07-27 2015-06-02 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
JP5627181B2 (ja) 2005-09-07 2014-11-19 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法
US7879818B2 (en) * 2005-12-23 2011-02-01 Janos Borbely Hyaluronic acid-based cross-linked nanoparticles
KR100737954B1 (ko) * 2006-01-03 2007-07-13 고려대학교 산학협력단 조직재생을 위한 히알루론산-기초된 주사형 하이드로겔
CN101686107B (zh) 2006-02-13 2014-08-13 数字方敦股份有限公司 使用可变fec开销和保护周期的流送和缓冲
US9270414B2 (en) 2006-02-21 2016-02-23 Digital Fountain, Inc. Multiple-field based code generator and decoder for communications systems
JP2009528438A (ja) * 2006-02-28 2009-08-06 ノボザイムス バイオポリマー アクティーゼルスカブ ヒアルロン酸誘導体
US7674781B2 (en) * 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
US7971129B2 (en) 2006-05-10 2011-06-28 Digital Fountain, Inc. Code generator and decoder for communications systems operating using hybrid codes to allow for multiple efficient users of the communications systems
US9432433B2 (en) 2006-06-09 2016-08-30 Qualcomm Incorporated Enhanced block-request streaming system using signaling or block creation
US9209934B2 (en) 2006-06-09 2015-12-08 Qualcomm Incorporated Enhanced block-request streaming using cooperative parallel HTTP and forward error correction
US9386064B2 (en) 2006-06-09 2016-07-05 Qualcomm Incorporated Enhanced block-request streaming using URL templates and construction rules
US9419749B2 (en) 2009-08-19 2016-08-16 Qualcomm Incorporated Methods and apparatus employing FEC codes with permanent inactivation of symbols for encoding and decoding processes
US9380096B2 (en) 2006-06-09 2016-06-28 Qualcomm Incorporated Enhanced block-request streaming system for handling low-latency streaming
US9178535B2 (en) 2006-06-09 2015-11-03 Digital Fountain, Inc. Dynamic stream interleaving and sub-stream based delivery
CN101501075B (zh) * 2006-08-04 2013-07-10 诺维信生物制药丹麦公司 支化透明质酸和制造方法
US20080070993A1 (en) * 2006-09-07 2008-03-20 Janos Borbely Additives for cosmetic products and the like
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
US20090023631A1 (en) * 2007-07-18 2009-01-22 Lorenc Z Paul Composition and Method of Use for Soft Tissue Augmentation/Drug Delivery
EP2178908B1 (en) * 2007-08-15 2013-07-10 Metamorefix Peptides and pharmaceutical compositions for treating connective tissue
US9237101B2 (en) 2007-09-12 2016-01-12 Digital Fountain, Inc. Generating and communicating source identification information to enable reliable communications
CA2719666C (en) 2008-04-04 2016-08-16 Glenn Prestwich Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US8932622B2 (en) * 2008-06-03 2015-01-13 Actamax Surgical Materials, Llc Tissue coating for preventing undesired tissue-to-tissue adhesions
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
KR20110042340A (ko) * 2008-08-05 2011-04-26 데이진 가부시키가이샤 하이드로겔
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
US9281847B2 (en) 2009-02-27 2016-03-08 Qualcomm Incorporated Mobile reception of digital video broadcasting—terrestrial services
US9288010B2 (en) 2009-08-19 2016-03-15 Qualcomm Incorporated Universal file delivery methods for providing unequal error protection and bundled file delivery services
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
US9917874B2 (en) 2009-09-22 2018-03-13 Qualcomm Incorporated Enhanced block-request streaming using block partitioning or request controls for improved client-side handling
JP5604072B2 (ja) * 2009-09-28 2014-10-08 テルモ株式会社 活性エステル化多糖およびその製造方法
FR2954945B1 (fr) * 2010-01-04 2012-01-06 Oreal Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
US20110280311A1 (en) 2010-05-13 2011-11-17 Qualcomm Incorporated One-stream coding for asymmetric stereo video
US9017712B2 (en) * 2010-07-12 2015-04-28 Shin Poong Pharmaceutical Co., Ltd. Filler composition for tissue reinforcement
US9596447B2 (en) 2010-07-21 2017-03-14 Qualcomm Incorporated Providing frame packing type information for video coding
US9456015B2 (en) 2010-08-10 2016-09-27 Qualcomm Incorporated Representation groups for network streaming of coded multimedia data
US9270299B2 (en) 2011-02-11 2016-02-23 Qualcomm Incorporated Encoding and decoding using elastic codes with flexible source block mapping
US8958375B2 (en) 2011-02-11 2015-02-17 Qualcomm Incorporated Framing for an improved radio link protocol including FEC
JP6062917B2 (ja) 2011-03-23 2017-01-18 ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション 泌尿器科の炎症の治療及び予防の方法
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции
US9253233B2 (en) 2011-08-31 2016-02-02 Qualcomm Incorporated Switch signaling methods providing improved switching between representations for adaptive HTTP streaming
US9843844B2 (en) 2011-10-05 2017-12-12 Qualcomm Incorporated Network streaming of media data
CZ2012136A3 (cs) * 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
US9294226B2 (en) 2012-03-26 2016-03-22 Qualcomm Incorporated Universal object delivery and template-based file delivery
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
FR3005056B1 (fr) * 2013-04-24 2016-04-01 Ayawane Hydrogel a base de polysaccharides natifs et/ou fonctionnalises, phosphates co-reticules
BR112015031457A2 (pt) * 2013-06-28 2017-07-25 Galderma Sa processo para preparar um produto do ácido hialurônico reticulado
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
ITUD20130119A1 (it) * 2013-09-12 2015-03-13 Limacorporate Spa Idrogel biocompatibile per uso biomedico o farmaceutico, polimero intermedio per realizzare detto idrogel biocompatibile e relativo metodo di realizzazione
US20150141910A1 (en) * 2013-11-14 2015-05-21 University Medical Pharmaceuticals Corporation Microneedles for therapeutic agent delivery with improved mechanical properties
US10294195B2 (en) 2014-01-31 2019-05-21 Seikagaku Corporation Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials
EP3397651B1 (en) 2015-12-29 2020-05-06 Galderma S.A. Carbohydrate crosslinker
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
US10898613B2 (en) 2016-09-21 2021-01-26 Nestlé Skin Health Sa Hyaluronic acid gel with a divalent zinc cation
AU2018240375C1 (en) 2017-03-22 2024-02-01 Ascendis Pharma A/S Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
WO2019001784A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa HYALURONIC ACID GEL WITH A DIVALENT CATION
CN107469090B (zh) * 2017-08-15 2020-05-12 浙江大学 可共载抗肿瘤药物和核酸药物的纳米载体及抗肿瘤药物纳米制剂
EP3659632A1 (en) 2018-11-29 2020-06-03 Nestlé Skin Health SA Post-crosslinking partial degradation of amide crosslinked hydrogels
US20220213233A1 (en) * 2019-04-19 2022-07-07 Jointherapeutics S.R.L. Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
CN110123741B (zh) * 2019-06-24 2022-02-08 中国医学科学院基础医学研究所 一种铁交联透明质酸纳米凝胶、其制备方法以及用途
CN110684211B (zh) * 2019-10-14 2022-07-12 宁夏妙朗生物科技有限公司 制备抵抗α-葡萄糖苷酶水解的交联右旋糖苷凝胶的方法
CA3160575A1 (en) 2019-12-02 2021-06-10 Johan Olsson High molecular weight esthetic compositions
CA3198795A1 (en) 2020-11-18 2022-05-27 Jeffrey Becker Complexing agent salt formulations of pharmaceutical compounds
WO2022109050A1 (en) * 2020-11-18 2022-05-27 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds
WO2023148619A1 (en) 2022-02-01 2023-08-10 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
CN114561046B (zh) * 2022-02-28 2023-10-27 江南大学 一种胍基透明质酸型抗菌水凝胶及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
MC2288A1 (fr) * 1990-05-04 1993-07-14 Perio Prod Ltd Systeme d'administration de medicament au niveau du colon
AU664858B2 (en) * 1991-08-16 1995-12-07 Miles A. Galin Medicament coated refractive anterior chamber ocular implant
IT1254170B (it) * 1991-12-18 1995-09-11 Mini Ricerca Scient Tecnolog Membrane composite per la rigenerazione guidata di tessuti
CA2076732C (en) * 1992-04-17 2006-05-09 Kimberly-Clark Worldwide, Inc. Modified polysaccharides having improved absorbent properties and process for the preparation thereof
JPH06154596A (ja) * 1992-11-18 1994-06-03 Sanyo Chem Ind Ltd 耐塩安定性吸収剤及びその製法
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
JPH0959303A (ja) * 1995-08-22 1997-03-04 Shiseido Co Ltd 生体適合性ヒアルロン酸ゲル及びその用途
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.

Also Published As

Publication number Publication date
DE69903351D1 (de) 2002-11-07
DK1144459T4 (da) 2011-06-06
HK1041011A1 (en) 2002-06-28
TR200101324T2 (tr) 2001-09-21
CZ20011650A3 (cs) 2001-09-12
EP1144459B1 (en) 2002-10-02
ATE225371T1 (de) 2002-10-15
ZA200103799B (en) 2002-08-12
ES2184521T5 (es) 2011-06-13
PT1144459E (pt) 2003-01-31
EP1144459A2 (en) 2001-10-17
ITMI982440A1 (it) 2000-05-11
CZ296842B6 (cs) 2006-06-14
CA2350667A1 (en) 2000-05-18
NO20012315L (no) 2001-07-06
HUP0104296A3 (en) 2003-12-29
CN1131241C (zh) 2003-12-17
KR100674177B1 (ko) 2007-01-24
EP1144459B2 (en) 2011-02-23
CN1328573A (zh) 2001-12-26
HU229668B1 (en) 2014-04-28
NO20012315D0 (no) 2001-05-10
JP2002529550A (ja) 2002-09-10
DK1144459T3 (da) 2003-02-03
AU757102B2 (en) 2003-01-30
NZ511306A (en) 2003-05-30
HK1041011B (zh) 2004-10-08
KR20010101001A (ko) 2001-11-14
DE69903351T2 (de) 2003-07-03
HUP0104296A2 (hu) 2002-03-28
RU2230752C2 (ru) 2004-06-20
US6831172B1 (en) 2004-12-14
AU2660000A (en) 2000-05-29
WO2000027887A2 (en) 2000-05-18
IT1303735B1 (it) 2001-02-23
WO2000027887A3 (en) 2000-11-16
BR9915235A (pt) 2001-07-24
ES2184521T3 (es) 2003-04-01
DE69903351T3 (de) 2012-02-09

Similar Documents

Publication Publication Date Title
IL143063A0 (en) Cross-linked hyaluronic acids and medical uses thereof
CA2359318A1 (en) Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
GB9902652D0 (en) Process
HUP9600903A2 (en) Copolymers based on oxy-alkylene-glycol-alkenyl-ether and unsaturated dicarboxylic acid derivative, process for producing thereof and the use thereof
DK0991653T3 (da) Nye forbindelser
FR2754820B1 (fr) Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant
AU2003273466A1 (en) Polyamino acids functionalized by at least one hydrophobic group and the therapeutic applications thereof
EP1978031A3 (en) Tropoelastin derivatives
HUP9800467A3 (en) Use of hyaluronic acid for producing pharmaceutical compns. for the treatment of interstitial cystitis
DE69716586D1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
IL184227A0 (en) Biologically active peptides
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
JO2017B1 (en) Pharmaceutical formula for infectious residence
AU3524800A (en) Polycyclic polymers containing pendant cyclic anhydride groups
AU3188295A (en) Production of polymers of hydroxyalkanoic acids
IL93197A0 (en) Derivatives of 3-pyroglutamyl-thia-zolidine-4-carboxylic acid
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
ITMI922018A0 (it) Bassi polimeri dell'n-vinilpirrolidone monofunzionalizzati ad un estremo per la preparazione di coniugati con enzimi, polipeptidi farmaci
MY130723A (en) Accelerator for the production of polyamides from aminonitriles
CA2029062A1 (en) Biodegradable polymer compositions
FR2712892B1 (fr) Procédé de préparation de polyimides ou de leurs hydrolysats biodégradables.
AU680735B2 (en) Process for the manufacture of pharmaceutical grade ranitidine base
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
GB9416691D0 (en) Production of polymers of hydroxyalkanoic acid

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees